|Publication number||US7376451 B2|
|Application number||US 10/973,598|
|Publication date||May 20, 2008|
|Filing date||Oct 27, 2004|
|Priority date||Oct 27, 2004|
|Also published as||US20060089546, US20080194906|
|Publication number||10973598, 973598, US 7376451 B2, US 7376451B2, US-B2-7376451, US7376451 B2, US7376451B2|
|Inventors||Michael Joseph Mahony, John Erik Hershey, Glenn Alan Forman, Harold Woodruff Tomlinson, Jr., William Eugene Powell, III|
|Original Assignee||General Electric Company|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (14), Non-Patent Citations (1), Referenced by (7), Classifications (16), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
The invention relates generally to a system and method for obtaining physiological data measurements and providing certain optically induced treatment regimens, and more particularly to a system and method for optically measuring oximetric information and providing photodynamic therapy or tissue healing therapy through non-intrusive means.
There are numerous instances where oximetric measurements are necessary for the proper treatment of individuals experiencing some form of health crisis. For example, neonates, newborn babies with a birth weight of 1500 grams or less, are in a fragile state immediately after birth and for some time thereafter. Due to their fragility, any disturbance to them could be dangerous, and even life threatening. Neonates must be continually and extensively monitored so that the most efficacious medical regimen may be administered. Most physiological monitoring mechanisms incorporate extensive sensors and cabling which must be attached to the neonate, and such monitoring mechanisms lead to a tension between the need to monitor neonates and the need to disturb them as little as possible.
Two important measurements for neonates include detection of physical movement as a sign of life and estimation of cardiac and cardiopulmonary data, including pulse oximetry. Conventionally, pulse oximetry is often performed through an oximeter which is attached either at the finger or the ear and which measures the absorption of light of two different wavelengths. A pulse oximeter works by passing a beam of red and infrared light through a pulsating capillary bed. The ratio of red to infrared blood light transmitted gives a measure of the oxygen saturation of the blood. The measurements of the two different beams, which have two different wavelengths, usually straddle an isosbestic point, the wavelength at which the molar extinction coefficients are equal, i.e., the point at which the absorption spectra of two species cross each other. As shown in
Another conventional approach for obtaining pulse oximetry is found in U.S. Pat. No. 6,470,200, in which is disclosed a pacifier with an oximetric sensor. The sensor may be optionally equipped with wireless communications, for wirelessly reporting the measured oximetric data. This approach is not suitable for neonates, as they are not yet developed fully to the stage of being able to reliably handle a pacifier.
Another example of when oximetric monitoring is important is during a surgical procedure under a general anesthetic. Conventional anesthetic mechanisms are closed systems that re-circulate the anesthetic. Known anesthetic mechanisms utilize a canister that includes a carbon dioxide scrubber through which the expired outflow from the patient, including the anesthetic and expired air, is recycled. The carbon dioxide scrubber removes the carbon dioxide from the outflow. One known anesthetic mechanism uses BaralymeŽ as the scrubbing material and Sevoflurane™ as the anesthetic. Carbon dioxide scrubbers have an initial level of moisture, and through use become less moist. If a carbon dioxide scrubber becomes desiccated, a build up of carbon monoxide may occur in the scrubber, and that carbon monoxide may be added to the outflow. Carbon monoxide has an affinity for hemoglobin that is more than two hundred times greater than that for either oxygen or carbon dioxide, and the introduction of carbon monoxide in the outflow can lead to carboxyhemoglobin in levels that are dangerous to the patient.
Additionally, there are certain medical treatment regimens that are optically induced, namely that utilize light in a somewhat catalytic way. For example, light may be used to activate light-sensitive chemotherapy drugs. Also, light may be used to stimulate tissue growth and regeneration.
There exists a need for an efficacious methodology for gathering physiological data and for performing certain optically induced treatment regimens that is less disturbing to the patient.
The present invention describes a system and a method for obtaining physiological data measurements and for optically inducing therapeutic treatment.
One exemplary embodiment of the invention is a physiological data measurement system that includes a non-adhering signal emitting mechanism and a signal receiving mechanism. The signal emitting mechanism includes a monitoring mechanism configured to monitor physiological data of and provide support to a subject and at least one signal emitter module within the monitoring mechanism. The signal receiving mechanism is configured to receive signals emitted from the at least one signal emitter module.
Another exemplary embodiment of the invention is a treatment system that includes a non-adhering light emitting mechanism. The non-adhering light emitting mechanism includes an optical treatment array mechanism configured to provide optical treatment to and provide support for a subject and at least one light emitter module within the optical treatment array. The at least one light emitter module is configured to emit a light at a therapeutic wavelength.
Another exemplary embodiment of the invention is an incubating system that includes an incubator and a non-adhering physiological data measurement system configured to measure physiological data of and provide support to a subject.
One aspect of the incubating system embodiment includes a light emitting mechanism and a light receiving mechanism. The light emitting mechanism includes a monitoring pad configured to monitor physiological data of and provide support for a subject, and a single light emitter module within the monitoring pad and including a broadband light source. The light receiving mechanism is configured to receive light emitted from the broadband light source.
Another exemplary embodiment of the invention is a light emitting mechanism for use in a physiological data measurement device. The light emitting mechanism includes a non-adhering monitoring mechanism configured to measure physiological data of and provide support for a subject, and one or more light emitter modules within the monitoring mechanism, each of the light emitter modules being configured to emit light at at least two wavelengths.
Another exemplary embodiment of the invention is a method for obtaining physiological data measurements. The method includes determining an outline of a subject through a sequential transmission of light from a plurality of light emitter modules, sequentially turning on and off individual ones of the plurality of light emitter modules that are within the outline of the subject, and collecting data and estimating physiological data values.
Another exemplary embodiment of the invention is a method for ascertaining movement of a neonatal infant being monitored. The method includes determining an outline of a neonatal infant through a sequential transmission of light from a plurality of light emitter modules, collecting initial data on the initial outline of the neonatal infant, and then, re-determining a subsequent outline of the neonatal infant through another sequential transmission of light from the plurality of light emitter modules to ascertain whether the subsequent outline differs from the initial outline.
These and other advantages and features will be more readily understood from the following detailed description of preferred embodiments of the invention that is provided in connection with the accompanying drawings.
Embodiments of the invention described herein relate to a monitoring and/or treatment system utilizing a non-adhering interrogation mechanism. The non-adhering interrogation mechanism may employ optical spectra and/or electromagnetic field data to obtain physiological data measurements from a subject in a non-adhering way. By non-adhering is meant that physical adherence of sensors to the skin of a subject is not required to obtain physiological data measurements. Adhering sensors include those utilizing an adhesive of some sort to attach the sensor to a subject and those known finger and ear pulse oximeters which utilize a clamping force on the subject to retain attachment of the sensor.
Referring now to
The monitoring mechanism 102 may include a pad formed of a suitable fabric-like material. Since the subject patient 110 may lie on the monitoring pad 102, the pad (and any underlying structure) should be able to sustain the patient's weight while also providing support and comfort to the patient.
Within the monitoring pad 102 is a single light emitter module 112. The light emitter module 112 is preferably a broadband light source, and it may include solid state optoelectronics, such as a surface emission laser diode, that can be made to consume low levels of power, provide single-mode or multi-mode light, and be controlled by mechanical (MEMS) or electrical means to provide optical emission for a tunable spectrum of light.
The measurement system 100 also includes a light distributor 114 positioned between the subject 110 and the light emitter module 112. The light from the broadband light emitter module 112 is distributed by the light distributor 114. The light distributor 114 may be any suitable mechanism for distributing light, such as, for example, a Fresnel lens or a fiber optic array.
The light-sensing array 106 detects the light 170 transmitted and diffused forward through the subject 110. The light-sensing array 106 may be a two-dimensional light sensor, for example, a camera such as a CCD camera. The light-sensing array 106 serves to record an image of the subject 110 when the light emitter module 112 is activated. A shutter, either mechanical or electronic, serves to gate the light-sensing array 106 with the activation of the light emitter module 112 to reduce interference from ambient light. Alternatively, a narrow band filter may be utilized with the light-sensing array 106 to filter out ambient light, such as light at a wavelength of or shorter than about 600 nanometers.
Alternatively, instead of utilizing a broadband light emitter module 112 of the measurement system 100, a light emitter module 212 having multiple wavelengths can be used with a rotary filter wheel 214 positioned adjacent the light-sensing array 106 (
Next, as shown in
Alternative to incorporating the light emitter modules 312 in the monitoring pad 202, such flexible circuits may be incorporated within and be a part of a conventional heating or thermoelectric cooling pad (not shown). Further, the light emitter modules 312 may instead be incorporated within a fabric that is worn by or draped over or around a subject, such as, for example, a blanket, bed sheets, gown, or robe. The light emitter modules 312 in such a fabric would be an electronically or optically connected arrangement of metal or fiber pads, quantum dots, or nanofibrous electrodes forming leads about the subject 110. Additionally, instead of light emitter modules 312 that employ optical spectra to interrogate the subject as to various physiological data, electromagnetic sensors may be used to obtain electromagnetic field data in such a non-adhering interrogation mechanism.
The light emitter modules 312 may be arrayed in various spatial dispositions, each being positioned beneath an optically transparent surface window 313 that will be oriented normal to the emission path. Only one surface window 313 is schematically shown in
Each of the light emitter modules 312 are individually and repetitively turned on and off according to instructions from the controller 104. A scanner, or other similar mechanism, may be used to activate the light emitter modules 312 in a raster-scan format, completing one scan of all the light emitter modules 312 for each wavelength being used in the measurement system 200. Individual activation of the light emitter modules 312 allows for easy determination as to through what portion of the patient 110 the light is being transmitted and assists in determining an accurate and current position of the patient 110. Repetitive activation of the light emitter modules 312 allows for a greater amount of energy to be transmitted through the body of the patient 110, allowing for greater confidence in the results determined thereby. Activation of the light emitter modules 312 also may be localized to specific regions of the body (for example, the head) to monitor physiological parameters in those areas or for localizing delivery of a therapeutic wavelength.
The light emitter modules 312 are capable of emitting light at two or more wavelengths. Each light emitter module 312 includes an optical emitter, such as, for example, an LED, for each wavelength used in the measurement system 200. As shown in
Each of the wavelengths is used in estimating the saturation of hemoglobin. For example, if only two optical emitters 314, 316 are included within each light emitter module 312, one of the optical emitters emits light 170 at wavelength λ1, such as a red light, which is used to estimate the patient's blood's oxyhemoglobin saturation, and the other of the optical emitters emits light 170 at wavelength λ2, such as an infrared light, which is used to estimate the patient's deoxyhemoglobin level. The beams of red and infrared light are transmitted through a pulsating capillary bed within the patient 110. The ratio of red to infrared blood light transmitted gives a measure of the oxygen saturation of the blood. An addition of two more optical emitters 318, 320, each emitting light at a different wavelength λ3, λ4, allows for the estimation of the patient's blood's carboxyhemoglobin and methemoglobin conditions.
The optical emitters 314, 316, 318, 320 may be any suitable light emitting mechanism, such as, for example, VCSELs, a type of semiconductor laser with a laser beam emission that is perpendicular to the chip surface. Alternatively, the optical emitters 314, 316, 318, 320 may include optical conduits for VCSELs recessed below the surface of monitoring pad 202. The optical emitters 314, 316, 318, 320 may be made to diffuse the emitted light 170 and, in one embodiment, may be made to approximate a Lambertian radiator. Other suitable light emitting mechanisms include tunable lasers. Suitable lasers may be oriented to emit light in a direction perpendicular to the optically transparent surface window 313 of the monitoring pad 202 and properly collimated to transmit through a subject and, if necessary, through an incubator environment.
Neonatal patients 110, due to their small size, are relatively transparent, especially in certain body regions, to emitted light 170. Generally, neonates are placed within an incubator 150 without any clothing, and only a small diaper. Other, larger patients 110 are less transparent to emitted light 170 than neonates. Further, other larger patients usually are covered with a hospital gown and may also be covered with bed sheets and/or blankets. Conventional hospital gowns and bed sheets/blankets may not be transparent to emitted light 170. Clothing the patients 110 in gowns and bed sheets/blankets that are transparent to emitted light 170 would allow use of the measurement system 200 during a surgical procedure. Further, the measurement system 200 can be used for monitoring the patient 110 in his bed by placing the monitoring pad 202 on the bed and incorporating an optical sensor 116 as described in reference to
With specific reference to
The emitted light 170 is received by the optical sensor 322 and collimated by a lens 324. If the emitted light 170 is transmitted from a broadband light emitter module, then the collimated light is passed to a beam splitter 326, which splits the collimated light into a first beam 328 and a second beam 330. Instead of a beam splitter, a rotating filter wheel may alternatively be used to obtain sequential images from optical sensor 322 at different wavelengths. The first beam 328 is passed into an optical wavelength band pass filter 332, which has a band pass centered on a particular wavelength, such as wavelength λ1. Light within the wavelength λ1 is transmitted to a first detector 334. The second beam 330 is passed into an optical wavelength band pass filter 338, which has a band pass centered on a second particular wavelength, such as wavelength λ2. Optionally, and as shown, a mirror 336 may be incorporated between the beam splitter 326 and the optical wavelength band pass filter 338. Light within the wavelength λ2 is transmitted to a second detector 340. If the emitted light 170 is transmitted from the array of light emitter modules 312, the beam splitter 326 becomes unnecessary. Instead, the different wavelengths are distinguished by illuminating one wavelength at a time.
Output 270 from the detectors 334, 340 is sent to the controller 104 via a communications path 160. The communications path 160 may include any suitable communications medium, such as, for example, free space optical communications means like infrared, RF wireless, electrical cable, or optical fiber. It should be appreciated that if the emitted light 170 contains light with more than two wavelengths, such as four wavelengths λ1, λ2, λ3, λ4, the optical sensor 322 can be expanded to provide four band pass filters and four detectors.
Although the embodiments described with reference to
Alternatively, for neonate subjects 110, the incubator 150 may utilize multiple optical transmitters, such as VCSELs or LEDs, on an overhead shell surface. Such an incubator 150 may have a base layer underneath the subject 110 that includes a networked surface for communication, control and power. Power on the networked surface may be provided in ultra-low direct current voltage and include current limiting hardware. The overhead shell would remain optically clear and include VCSELs or LEDs and power conductors. The longer wavelength, near-infrared light penetrates tissues deeper than visible light, allowing transmission through a subject 110. Such light is also preferably pulsed, thus inhibiting tissue heating.
Referring now to
Next, at Step 415, the controller 104 selects light emitter modules within select regions of interest within the patient's silhouette and turns each of the selected light emitter modules in each region of interest on and off. The light emitter modules may be individually turned on and off, region by region. For example, if the regions of interest include the center of the head, part of the thoracic area, and part of the safenous area, the light emitter modules corresponding to those three regions would be turned on, individually, in one region (for example the head), followed by the second region (thoracic area), and then the third region (safenous area).
Sensor data is collected at Step 420 and physiological data values are estimated. The sensor data collected includes the sequential region illuminations of the patient 110, and this data is used to estimate physiological data values. This data is then logged. At Step 425, the outline of the patient 110 is again determined, and this second outline is compared with the previously determined outline. A difference in the outlines signifies movement of the patient 110. At Step 430, a determination is made whether there is a difference in the silhouettes of the patient 110. If there is no change in the silhouettes, the process can move back to Step 415. Conversely, if there is a determined change in the silhouettes, a report is generated at Step 435 of movement by the patient 110. Finally, at Step 440, the new silhouette is stored, replacing the previously stored silhouette, and the process moves back to Step 415.
While the measurement system embodiments have been described and shown for the application of obtaining physiological data through a non-adhering interrogation mechanism, it should be appreciated that the same embodiments may be utilized for a different purpose. For example, such a non-adhering interrogation mechanism may include light emitters that emit light at a therapeutic wavelength that, for example, may enable the activation of light-sensitive chemotherapy drugs (photodynamic therapy). Such photodynamic therapy may be used, for example, for the destruction of cancer. Alternatively, such a non-adhering interrogation mechanism may be used to introduce light at a therapeutic wavelength to react with cytochromes in cells of the subject 110 that respond to light and color to stimulate tissue growth and regeneration. In such treatment systems, the monitoring mechanism would instead function as an optical treatment array mechanism. Another such photodynamic therapy may include the shining of a fluorescent light on a neonate for the treatment of hyperbiliruben.
While the invention has been described in detail in connection with only a limited number of embodiments, it should be readily understood that the invention is not limited to such disclosed embodiments. Rather, the invention can be modified to incorporate any number of variations, alterations, substitutions or equivalent arrangements not heretofore described, but which are commensurate with the spirit and scope of the invention. Additionally, while various embodiments of the invention have been described, it is to be understood that aspects of the invention may include only some of the described embodiments. Accordingly, the invention is not to be seen as limited by the foregoing description, but is only limited by the scope of the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3463142 *||Jul 5, 1966||Aug 26, 1969||Trw Inc||Blood content monitor|
|US4895155 *||Oct 24, 1988||Jan 23, 1990||Lee Arnold St J||Method for estimating blood oxygen saturation|
|US5313941 *||Jan 28, 1993||May 24, 1994||Braig James R||Noninvasive pulsed infrared spectrophotometer|
|US5339223 *||Mar 24, 1993||Aug 16, 1994||Ohmeda Inc.||Servocontrol for fiberoptic phototherapy pad|
|US5978691 *||Jul 10, 1997||Nov 2, 1999||Mills; Alexander Knight||Device and method for noninvasive continuous determination of blood gases, pH, hemoglobin level, and oxygen content|
|US5995856 *||Nov 22, 1995||Nov 30, 1999||Nellcor, Incorporated||Non-contact optical monitoring of physiological parameters|
|US6070093 *||Dec 2, 1997||May 30, 2000||Abbott Laboratories||Multiplex sensor and method of use|
|US6088605 *||Feb 21, 1997||Jul 11, 2000||Diasense, Inc.||Method and apparatus for non-invasive blood glucose sensing|
|US6470200||Feb 12, 2001||Oct 22, 2002||The United States Of America As Represented By The Secretary Of The Army||Pacifier pulse oximeter sensor|
|US6526298 *||Oct 20, 2000||Feb 25, 2003||Abbott Laboratories||Method for the non-invasive determination of analytes in a selected volume of tissue|
|US6596016 *||Apr 19, 2000||Jul 22, 2003||The Board Of Trustees Of The Leland Stanford Junior University||Phototherapy of jaundiced newborns using garments containing semiconductor light-emitting devices|
|US6611320 *||Sep 7, 2000||Aug 26, 2003||Optoq Ab||Method and apparatus|
|US6635491 *||Jul 28, 2000||Oct 21, 2003||Abbott Labortories||Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration|
|US20030189363 *||Apr 2, 2003||Oct 9, 2003||Albert Artsvelyan||Adjustable armrest cushion|
|1||"Noninvasive Optical Method of Measuring Tissue and Arterial Saturation: An Application to Absolute Pulse Oximetry of the Brain", Maria A. Franceschini, E. Gratton and S. Fantini, Optical Society of America (1999)-pp. 829-831.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8219170 *||Sep 20, 2006||Jul 10, 2012||Nellcor Puritan Bennett Llc||System and method for practicing spectrophotometry using light emitting nanostructure devices|
|US8888701 *||Jan 25, 2012||Nov 18, 2014||Valencell, Inc.||Apparatus and methods for monitoring physiological data during environmental interference|
|US8989830||Sep 12, 2014||Mar 24, 2015||Valencell, Inc.||Wearable light-guiding devices for physiological monitoring|
|US9042967||May 20, 2009||May 26, 2015||University Health Network||Device and method for wound imaging and monitoring|
|US9044180||Jul 18, 2012||Jun 2, 2015||Valencell, Inc.||Noninvasive physiological analysis using excitation-sensor modules and related devices and methods|
|US9131312||May 8, 2014||Sep 8, 2015||Valencell, Inc.||Physiological monitoring methods|
|US20120197093 *||Jan 25, 2012||Aug 2, 2012||Leboeuf Steven Francis||Apparatus and methods for monitoring physiological data during environmental interference|
|U.S. Classification||600/310, 600/323|
|International Classification||A61B5/00, A61B5/1455|
|Cooperative Classification||A61N5/062, A61N5/0621, A61B2562/0233, A61B5/0064, A61N5/0601, A61B5/14552, A61B2562/046, A61B5/11, A61B5/1464|
|European Classification||A61B5/1464, A61B5/1455N2, A61B5/00P1A|
|Oct 27, 2004||AS||Assignment|
Owner name: GENERAL ELECTRIC COMPANY, NEW YORK
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAHONY, MICHAEL JOSEPH;HERSHEY, JOHN ERIK;FORMAN, GLENN ALAN;AND OTHERS;REEL/FRAME:015935/0306;SIGNING DATES FROM 20041020 TO 20041022
|Sep 23, 2011||FPAY||Fee payment|
Year of fee payment: 4
|Dec 31, 2015||REMI||Maintenance fee reminder mailed|